Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics
- PMID: 14718398
- DOI: 10.1373/clinchem.2003.028506
Characterization of amplifiable, circulating RNA in plasma and its potential as a tool for cancer diagnostics
Abstract
Background: Several recent reports have described the detection of circulating, cancer-related RNA molecules in serum or plasma from cancer patients, but little is known about the biology of this extracellular RNA. We aimed to determine how RNA is protected against degradation in serum, to optimize RNA isolation from large volumes of serum, and to test our optimized assays for serum-based cancer detection.
Methods: We used quantitative reverse transcription-PCR (QRT-PCR) analysis to investigate the isolation and biology of extracellular plasma RNA. We then examined the presence of amplifiable RNA transcripts in plasma and serum from controls and from patients with esophageal cancer and malignant melanoma.
Results: We found that extracellular RNA in plasma is highly degraded and can be isolated most efficiently by guanidinium-phenol extraction followed by precipitation. Extracellular RNA is stable in serum for up to 3 h but is destroyed immediately by addition of detergents. Extracellular RNA can be captured on 0.2 microm filters, allowing concentration of RNA from several milliliters of plasma. When we concentrated RNA from up to 4 mL of serum, detection of cancer-related transcripts in serum from cancer patients and controls was infrequent and inconsistent.
Conclusions: Extracellular RNA is most likely protected within protein or lipid vesicles, possibly apoptotic bodies, which can be disrupted by detergents. Despite optimizing many aspects of plasma RNA detection, we were unable to reproducibly detect cancer-related transcripts. Our data suggest that measurement of circulating RNA may not be a good approach to early cancer diagnosis.
Similar articles
-
Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma.Oncol Rep. 2001 Jan-Feb;8(1):115-8. doi: 10.3892/or.8.1.115. Oncol Rep. 2001. PMID: 11115581
-
Analysis of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction for tyrosinase and MART-1 after mononuclear cell collection with cell preparation tubes: a comparison with the whole blood guanidinium isothiocyanate RNA isolation method.Melanoma Res. 2000 Apr;10(2):119-26. Melanoma Res. 2000. PMID: 10803712
-
Detection of tumor-associated circulating mRNA in patients with disseminated malignant melanoma.Ann N Y Acad Sci. 2001 Sep;945:189-91. Ann N Y Acad Sci. 2001. PMID: 11708477
-
Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction.J Clin Oncol. 2003 Mar 1;21(5):767-73. doi: 10.1200/JCO.2003.01.128. J Clin Oncol. 2003. PMID: 12610172 Review.
-
Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?Lung Cancer. 2005 Jul;49(1):1-12. doi: 10.1016/j.lungcan.2004.12.008. Lung Cancer. 2005. PMID: 15949585 Review.
Cited by
-
Quantification of BCR-ABL mRNA in plasma/serum of patients with chronic myelogenous leukemia.Int J Med Sci. 2012;9(10):901-8. doi: 10.7150/ijms.4655. Epub 2012 Nov 12. Int J Med Sci. 2012. PMID: 23155364 Free PMC article.
-
Characterization of RNA in saliva.Clin Chem. 2006 Jun;52(6):988-94. doi: 10.1373/clinchem.2005.063206. Epub 2006 Apr 6. Clin Chem. 2006. PMID: 16601067 Free PMC article.
-
Developmental Origins of Chronic Lung Diseases. Mechanical Stretch, Micro-RNAs, and Hydrogels.Am J Respir Cell Mol Biol. 2018 Aug;59(2):267-270. doi: 10.1165/rcmb.2018-0092RO. Am J Respir Cell Mol Biol. 2018. PMID: 29641225 Free PMC article. No abstract available.
-
The Interactions of microRNA and Epigenetic Modifications in Prostate Cancer.Cancers (Basel). 2013 Aug 9;5(3):998-1019. doi: 10.3390/cancers5030998. Cancers (Basel). 2013. PMID: 24202331 Free PMC article.
-
Circulating microRNA expression profiling and bioinformatics analysis of dysregulated microRNAs of patients with coronary artery disease.Medicine (Baltimore). 2018 Jul;97(27):e11428. doi: 10.1097/MD.0000000000011428. Medicine (Baltimore). 2018. PMID: 29979444 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources